Epithelial-to-Mesenchymal Transition and Phenotypic Marker Evaluation in Human, Canine, and Feline Mammary Gland Tumors

被引:8
作者
Sammarco, Alessandro [1 ,2 ]
Gomiero, Chiara [1 ]
Beffagna, Giorgia [1 ,3 ]
Cavicchioli, Laura [1 ]
Ferro, Silvia [1 ]
Michieletto, Silvia [4 ]
Orvieto, Enrico [5 ]
Patruno, Marco [1 ]
Zappulli, Valentina [1 ]
机构
[1] Univ Padua, Dept Comparat Biomed & Food Sci, I-35020 Padua, Italy
[2] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA
[3] Univ Padua, Dept Cardiothoracovasc Sci & Publ Hlth, I-35128 Padua, Italy
[4] IRCCS, Ist Oncol Veneto, Breast Surg Unit, I-35128 Padua, Italy
[5] Santa Maria Misericordia Hosp, Dept Pathol, I-45100 Rovigo, Italy
来源
ANIMALS | 2023年 / 13卷 / 05期
关键词
E-cadherin; epithelial-to-mesenchymal transition; mammary tumors; SNAIL; TWIST; ZEB; E-CADHERIN; BREAST-CANCER; BETA-CATENIN; TRANSCRIPTIONAL REPRESSOR; PROGNOSTIC-FACTOR; EXPRESSION; SNAIL; CD44; ZEB1; CARCINOMAS;
D O I
10.3390/ani13050878
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Simple Summary In this study we addressed the analysis of human breast cancer and canine and feline mammary tumors with regard to the expression, at either gene or protein level, of some molecules that are related to the capacity of an epithelial cell to become mesenchymal (epithelial-to-mesenchymal transition), acquiring higher ability to metastasize. In our samples, some typical markers of this transition were not higher at mRNA levels in tumors than in healthy tissues, indicating that some other markers should be investigated. Instead, at protein levels, some molecules such as vimentin and E-cadherin were indeed associated with higher aggressiveness, being potential useful markers. As already described in the literature, we also demonstrated that feline mammary tumors are close to an aggressive subtype of human breast cancer called triple negative, whereas canine mammary tumors are more similar to the less aggressive subtype of human breast cancer that expresses hormonal receptors. Epithelial-to-mesenchymal transition (EMT) is a process by which epithelial cells acquire mesenchymal properties. EMT has been closely associated with cancer cell aggressiveness. The aim of this study was to evaluate the mRNA and protein expression of EMT-associated markers in mammary tumors of humans (HBC), dogs (CMT), and cats (FMT). Real-time qPCR for SNAIL, TWIST, and ZEB, and immunohistochemistry for E-cadherin, vimentin, CD44, estrogen receptor (ER), progesterone receptor (PR), ERBB2, Ki-67, cytokeratin (CK) 8/18, CK5/6, and CK14 were performed. Overall, SNAIL, TWIST, and ZEB mRNA was lower in tumors than in healthy tissues. Vimentin was higher in triple-negative HBC (TNBC) and FMTs than in ER+ HBC and CMTs (p < 0.001). Membranous E-cadherin was higher in ER+ than in TNBCs (p < 0.001), whereas cytoplasmic E-cadherin was higher in TNBCs when compared with ER+ HBC (p < 0.001). A negative correlation between membranous and cytoplasmic E-cadherin was found in all three species. Ki-67 was higher in FMTs than in CMTs (p < 0.001), whereas CD44 was higher in CMTs than in FMTs (p < 0.001). These results confirmed a potential role of some markers as indicators of EMT, and suggested similarities between ER+ HBC and CMTs, and between TNBC and FMTs.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines
    Guan, Feng
    Handa, Kazuko
    Hakomori, Sen-itiroh
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (18) : 7461 - 7466
  • [32] Hydrogen Peroxide Enhances TGFβ-mediated Epithelial-to-Mesenchymal Transition in Human Mammary Epithelial MCF-10A Cells
    Iizuka, Daisuke
    Sasatani, Megumi
    Barcellos-Hoff, Mary Helen
    Kamiya, Kenji
    [J]. ANTICANCER RESEARCH, 2017, 37 (03) : 987 - 995
  • [33] Anti-Tumor Effects of Paeoniflorin on Epithelial-To-Mesenchymal Transition in Human Colorectal Cancer Cells
    Zhang, Zia-Wei
    Li, Li-Xin
    Wu, Wei-Zhong
    Pan, Ting-Jia
    Yang, Zhao-Shuo
    Yang, Yun-Ke
    [J]. MEDICAL SCIENCE MONITOR, 2018, 24 : 6405 - 6413
  • [34] PUMA Cooperates with p21 to Regulate Mammary Epithelial Morphogenesis and Epithelial-To-Mesenchymal Transition
    Zhang, Yanhong
    Yan, Wensheng
    Jung, Yong Sam
    Chen, Xinbin
    [J]. PLOS ONE, 2013, 8 (06):
  • [35] Epithelial-to-mesenchymal transition confers resistance to apoptosis in three murine mammary epithelial cell lines
    Robson, Ewan J. D.
    Khaled, Walid T.
    Abell, Kathrine
    Watson, Christine J.
    [J]. DIFFERENTIATION, 2006, 74 (05) : 254 - 264
  • [36] The Natural Alkaloid Piperlongumine Inhibits Metastatic Activity and Epithelial-to-Mesenchymal Transition of Triple-Negative Mammary Carcinoma Cells
    Delaney, Leanne M.
    Farias, Nathan
    Ghassemi Rad, Javad
    Fernando, Wasundara
    Annan, Henry
    Hoskin, David W.
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2021, 73 (11-12): : 2397 - 2410
  • [37] Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors
    Bergholtz, Helga
    Lien, Tonje
    Lingaas, Frode
    Sorlie, Therese
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2022, 27 (02) : 171 - 183
  • [38] Neuropilin-2 acts a critical determinant for epithelial-to-mesenchymal transition and aggressive behaviors of human head and neck cancer
    Ahn, Min-Hye
    Kim, Ji-Hoon
    Choi, Su-Jung
    Kim, Hyun-Ji
    Park, Dong-Guk
    Oh, Kyu-Young
    Yoon, Hye-Jung
    Hong, Seong-Doo
    Lee, Jae-Il
    Shin, Ji-Ae
    Cho, Sung-Dae
    [J]. CELLULAR ONCOLOGY, 2024, 47 (02) : 497 - 511
  • [39] Berberine Reverses Epithelial-to-Mesenchymal Transition and Inhibits Metastasis and Tumor-Induced Angiogenesis in Human Cervical Cancer Cells
    Chu, Shu-Chen
    Yu, Cheng-Chia
    Hsu, Li-Sung
    Chen, Kuo-Shuen
    Su, Mei-Yu
    Chen, Pei-Ni
    [J]. MOLECULAR PHARMACOLOGY, 2014, 86 (06) : 609 - 623
  • [40] Docetaxel Inhibits Epithelial-Mesenchymal Transition in Human Mammary Cells
    Beerkens, Samuel J.
    King, Jessica J.
    Irving, Kelly L.
    Bhatia, Sugandha
    Thompson, Erik W.
    Smith, Nicole M.
    Iyer, K. Swaminathan
    Evans, Cameron W.
    [J]. MOLECULAR PHARMACEUTICS, 2023, 21 (01) : 53 - 61